Archive for July 2013

In late 2012, an outbreak of fungal meningitis brought national attention to compounding pharmacies, the sterility and regulation of their compounded products, and the potential patient risks associated with compounded medications. At the heart of the outbreak was a medication called methylprednisolone acetate, a preservative free injectable steroid that was produced at the New England…

Read More